29 results
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Review Elagolix ... the FDA for the treatment ... #Pharmacology #Elagolix ... #Orilissa #Review ... #Overview
Alprazolam - short-acting benzodiazepine (GABA Receptor Modulator) used in the treatment of anxiety disorders. FDA approved
Modulator) used in the treatment ... #Pharmacology #Alprazolam ... #Xanax #Overview ... #Review
Metformin - oral antihyperglycemic agent for treatement of type II diabetes. 8th most prescribed drug in
antihyperglycemic agent for treatement ... #Pharmacology #Metformin ... Fortamet #AMPK #Overview ... #Review
Amlodipine - calcium channel blocker for the treatment of hypertension and CAD. 5th most prescribed drug
blocker for the treatment ... #Pharmacology #Amlodipine ... CalciumChannelBlocker #CCB #Overview ... #Review
Lisinopril - ACE inhibitor used for the treatment of hypertension and heart failure. 3rd most prescribed
inhibitor used for the treatment ... #Pharmacology #Lisinopril ... AngiotensinConvertingEnzyme #Inhibitor #Overview ... #Review
Daptomycin  - Antibiotics Class Overview

Mechanism: Lipopeptide antibiotic – forms transmembrane channels and depolarizes cells.
Antibiotics Class Overview ... and depolarizes cells ... cidal nature) #Pharmacology ... #Antibiotics #Review ... #Overview #Daptomycin
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Migraine Treatment ... Overview • ... • Pathophysiology ... Prophylactic Treatment ... #management #pharmacology
Venlafaxine. Potent SNRI approved in 1993 for the treatment of depression.

#Pharmacology #Venlaxafine #Effexor #SNRI #Overview #Review
in 1993 for the treatment ... #Pharmacology #Venlaxafine ... Effexor #SNRI #Overview ... #Review
Anastrozole is a Selective non-steroidal aromatase Inhibitor. Used for the treatment of breast cancer in postmenopausal
Used for the treatment ... and in cancer cells ... #pharmacology #overview ... druginformation #treatment
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
Lymphoproliferative Disorders - Differential ... Responsive to Treatment ... growth, response to treatment ... Classification #pathophysiology ... Diagnosis #NonHodgkin #differential